About N-[2-methyl-5-[[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]carbamoyl]phenyl]-2-(propan-2-ylamino)pyrimidine-5-carboxamide
N-[2-methyl-5-[[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]carbamoyl]phenyl]-2-(propan-2-ylamino)pyrimidine-5-carboxamide (PubChem CID 90655285) has the molecular formula C29H34F3N7O2
and a molecular weight of 569.63 g/mol. Its IUPAC name is N-[2-methyl-5-[[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]carbamoyl]phenyl]-2-(propan-2-ylamino)pyrimidine-5-carboxamide.
Molecular Properties
| Compound Name | N-[2-methyl-5-[[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]carbamoyl]phenyl]-2-(propan-2-ylamino)pyrimidine-5-carboxamide |
| PubChem CID | 90655285 |
| Molecular Formula | C29H34F3N7O2 |
| Molecular Weight | 569.63 g/mol |
| Exact Mass | 569.27 |
| IUPAC Name | N-[2-methyl-5-[[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]carbamoyl]phenyl]-2-(propan-2-ylamino)pyrimidine-5-carboxamide |
| SMILES | Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1NC(=O)c1cnc(NC(C)C)nc1 |
| InChI | InChI=1S/C29H34F3N7O2/c1-18(2)35-28-33-15-22(16-34-28)27(41)37-25-13-20(6-5-19(25)3)26(40)36-23-8-7-21(24(14-23)29(30,31)32)17-39-11-9-38(4)10-12-39/h5-8,13-16,18H,9-12,17H2,1-4H3,(H,36,40)(H,37,41)(H,33,34,35) |
| InChIKey | ZCMYRJKAOMVSNJ-UHFFFAOYSA-N |
| XLogP | 4.88 |
| TPSA | 102.49 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 8 |
| Heavy Atoms | 41 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
| MW ≤ 500 | 569.63 |
| LogP ≤ 5 | 4.88 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 7 |
Analyze N-[2-methyl-5-[[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]carbamoyl]phenyl]-2-(propan-2-ylamino)pyrimidine-5-carboxamide with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of N-[2-methyl-5-[[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]carbamoyl]phenyl]-2-(propan-2-ylamino)pyrimidine-5-carboxamide?
The IUPAC name of N-[2-methyl-5-[[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]carbamoyl]phenyl]-2-(propan-2-ylamino)pyrimidine-5-carboxamide (CID 90655285) is N-[2-methyl-5-[[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]carbamoyl]phenyl]-2-(propan-2-ylamino)pyrimidine-5-carboxamide.
What is the SMILES notation for N-[2-methyl-5-[[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]carbamoyl]phenyl]-2-(propan-2-ylamino)pyrimidine-5-carboxamide?
The canonical SMILES for N-[2-methyl-5-[[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]carbamoyl]phenyl]-2-(propan-2-ylamino)pyrimidine-5-carboxamide is Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1NC(=O)c1cnc(NC(C)C)nc1.
What is the InChIKey of N-[2-methyl-5-[[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]carbamoyl]phenyl]-2-(propan-2-ylamino)pyrimidine-5-carboxamide?
The InChIKey is ZCMYRJKAOMVSNJ-UHFFFAOYSA-N. The full InChI is InChI=1S/C29H34F3N7O2/c1-18(2)35-28-33-15-22(16-34-28)27(41)37-25-13-20(6-5-19(25)3)26(40)36-23-8-7-21(24(14-23)29(30,31)32)17-39-11-9-38(4)10-12-39/h5-8,13-16,18H,9-12,17H2,1-4H3,(H,36,40)(H,37,41)(H,33,34,35).
What are the key properties of N-[2-methyl-5-[[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]carbamoyl]phenyl]-2-(propan-2-ylamino)pyrimidine-5-carboxamide?
N-[2-methyl-5-[[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]carbamoyl]phenyl]-2-(propan-2-ylamino)pyrimidine-5-carboxamide has a molecular weight of 569.63 g/mol, XLogP of 4.88, 8 rotatable bonds, 3 hydrogen bond donors, and 7 hydrogen bond acceptors.
Where does this data come from?
All data for N-[2-methyl-5-[[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]carbamoyl]phenyl]-2-(propan-2-ylamino)pyrimidine-5-carboxamide is sourced from PubChem (CID 90655285), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).